Teva Pharmaceutical

Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too
Fierce Pharma
Teva Pharmaceutical
Pharma CEOs
Kåre Schultz
executive pay
Flag link:
Teva Donating More Than 10 Million Doses of Hydroxychloroquine as Potential COVID-19 Treatment
Teva Donating More Than 10 Million Doses of Hydroxychloroquine as Potential COVID-19 Treatment
Motley Fool
Teva Pharmaceutical
Bayer
hydroxychloroquine
COVID-19
Flag link:
Teva and Mylan to jumpstart production of old malaria drug to fight the novel coronavirus
Teva and Mylan to jumpstart production of old malaria drug to fight the novel coronavirus
Stat
Teva Pharmaceutical
Mylan
malaria
hydroxychloroquine
COVID-19
Flag link:
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round
Fierce Pharma
Perrigo
Catalent
Teva Pharmaceutical
ProAir HFA
asthma
COPD
generics
Flag link:
Teva Calls on FDA to Make Copaxone a Biologic as Part of March Transition
Teva Calls on FDA to Make Copaxone a Biologic as Part of March Transition
RAPS.org
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
FDA
biologics
Flag link:
Teva Drug Fails to Beat Placebo in Pediatric Tourette Patient Trials
Teva Drug Fails to Beat Placebo in Pediatric Tourette Patient Trials
Xconomy
Teva Pharmaceutical
pediatric
Tourette syndrome
clinical trials
deutetrabenazine
Flag link:
After years of business and lawsuit-fueled decline, is a Teva turnaround in sight?
After years of business and lawsuit-fueled decline, is a Teva turnaround in sight?
Endpoints
Teva Pharmaceutical
Kåre Schultz
Flag link:
Teva Pharmaceutical Reports a Step Back in 2019
Teva Pharmaceutical Reports a Step Back in 2019
Motley Fool
Teva Pharmaceutical
earnings
Flag link:
Active Biotech is back, with one last bid for the failed MS drug Teva discarded
Active Biotech is back, with one last bid for the failed MS drug Teva discarded
Endpoints
Teva Pharmaceutical
Active Biotech
laquinimod
MS
multiple sclerosis
Flag link:
Teva's Ajovy finally gets its autoinjector nod. Can it close the gap with Amgen, Lilly meds?
Teva's Ajovy finally gets its autoinjector nod. Can it close the gap with Amgen, Lilly meds?
Fierce Pharma
Teva Pharmaceutical
Ajovy
migraines
autoinjectors
FDA
CGRPs
Flag link:
Six Drug Companies Subpoenaed In Federal Opioid Investigation
Six Drug Companies Subpoenaed In Federal Opioid Investigation
Forbes
opioids
opioid crisis
Teva Pharmaceutical
McKesson
Mallinckrodt
AmerisourceBergen
JNJ
Amneal
Flag link:
Teva, others talk settlements with feds in yearslong generics price fixing probe: report
Teva, others talk settlements with feds in yearslong generics price fixing probe: report
Fierce Pharma
Teva Pharmaceutical
generics
price fixing
Taro Pharmaceuticals
Flag link:
Teva forms academic R&D pacts to further biopharma strategy
Teva forms academic R&D pacts to further biopharma strategy
Fierce Biotech
Teva Pharmaceutical
Israel
cancer
oncology
R&D
Flag link:
Patient charity to pay $4M to settle kickback allegations
Patient charity to pay $4M to settle kickback allegations
Beckers Hospital Review
kickbacks
Medicare
Medicare fraud
MS
multiple sclerosis
Teva Pharmaceutical
Biogen
Novartis
Flag link:
Teva forecasts 'tenfold' growth for new launch Austedo. Why don't analysts agree?
Teva forecasts 'tenfold' growth for new launch Austedo. Why don't analysts agree?
Fierce Pharma
Teva Pharmaceutical
Austedo
Huntington's disease
tardive dyskinesia
Flag link:
31 biopharmas at high risk of bankruptcy in 2020
31 biopharmas at high risk of bankruptcy in 2020
Biopharma Dive
bankruptcy
Teva Pharmaceutical
Bausch Health
Novavax
Flag link:
Top 10 pharma settlements since 2018
Top 10 pharma settlements since 2018
Fierce Pharma
settlements
Reckitt Benckiser
JNJ
Bayer
Allergan
Actelion
Purdue Pharma
Teva Pharmaceutical
Endo
Teikoku
Insys
Pfizer
GSK
Astellas
Amgen
Flag link:
Teva Pharmaceuticals To Resume Production Of Scarce Childhood Cancer Drug Vincristine
Teva Pharmaceuticals To Resume Production Of Scarce Childhood Cancer Drug Vincristine
Forbes
Teva Pharmaceutical
vincristine
chemotherapy
pediatric cancer
drug manufacturing
Flag link:
Pharma Giant Teva Reported Lagging Earnings — Here's Why Shares Rallied
Pharma Giant Teva Reported Lagging Earnings — Here's Why Shares Rallied
Investors Business Daily
Teva Pharmaceutical
earnings
Flag link:
Say hello to Roche's worst-case scenario: Teva's Rituxan biosim set to launch in U.S.
Say hello to Roche's worst-case scenario: Teva's Rituxan biosim set to launch in U.S.
Fierce Pharma
Roche
Teva Pharmaceutical
Celltrion
Rituxan
biosimilars
MabThera
Truxima
Flag link:

Pages